Price target
8.470.000.00%
The 13 analysts offering 1 year price forecasts for 8EM have a max estimate of — and a min estimate of —.
Analyst rating
Based on 19 analysts giving stock ratings to 8EM in the past 3 months.
EPS
0.00
Reported
Estimate
Reported
Estimate
Surprise
Revenue
0.00
Reported
Estimate
Reported
Estimate
Surprise
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
8EM EPS for the last quarter is −0.67 EUR despite the estimation of −0.67 EUR. In the next quarter EPS is expected to reach −0.34 EUR. Track more of Editas Medicine Inc. financials and stay on top of what is up with the company.
In the next quarter Editas Medicine Inc. revenue is expected to reach 27.22 M EUR. Check out Editas Medicine Inc. revenue and earnings and make informed decisions.
According to analysts, 8EM price target is 8.47 EUR with a max estimate of 13.99 EUR and a min estimate of 3.73 EUR. Check if this forecast comes true in a year, meanwhile watch Editas Medicine Inc. stock price chart and keep track of the current situation with 8EM news and stock market news.
We've gathered opinions of 19 analysts rating 8EM stock in the past 3 months. After counting all points of view, the overall rating was calculated as buy. Note that it's not a trading advice — your own analysis is still required.